Person: Daniel Friedman

Dr Asimina Arvanitaki

Dr Asimina Arvanitaki has been named the inaugural Stavros Niarchos Foundation Aristarchus Chair in Theoretical physics at the Perimeter Institute. Arvanitaki was selected for her research which focuses on the precision frontier of particle physics (particle physics without the colliders), using high-precision measurements seeking insights into the nature of dark matter and particle interactions. The…

Duncan Hawthorne

Duncan Hawthorne is stepping down as president and CEO of Bruce Power to take up equivalent positions with Horizon Nuclear Power in the UK. CFO Kevin Kelly will serve as acting president while the company conducts a search for a new CEO. Hawthorne joined Bruce Power in 2001 when it was principally owned by British…

Kathleen Walsh

Kathleen Walsh has been appointed interim executive director of Evidence for Democracy for the next year while Dr Katie Gibbs is on parental leave. Walsh has a strong background in policy advocacy and campaigning. She holds a master’s degree in development studies from the London School of Economics and a degree in public affairs and…

Daniel Friedman

Daniel Friedman is stepping down as CEO of MacDonald Dettwiler & Associates Ltd after 21 years at the helm. He is being replaced by US-based Howard Lance, former CEO of Harris Corp. The change in the top spot is intended to help MDA expand in the US market. Lance comes to MDA from Blackstone Group’s…

Dr Pascal Spothelfer

Dr Pascal Spothelfer has been appointed president and CEO of Genome British Columbia, replacing the retiring Dr Alan Winter. Spothelfer has a strong background in corporate management and social sciences and humanities knowledge grounded in a legal education. He holds a PhD in law from the Univ of Basel (Switzerland) and an MBA from INSEAD…